United States Antimony Corporation 8-K Filings

United States Antimony Corporation (UAMY) announced that its Board of Directors has authorized a share repurchase program for up to $100 million of its existing and outstanding common stock. The authorization was disclosed together with a press release dated August 19, 2026.

The company may repurchase shares from time to time in open-market and privately negotiated transactions, through block trades, or via trading plans established under Rule 10b5-1, and intends to conduct open-market repurchases in accordance with Rule 10b-18. The program has no fixed expiration date, does not obligate the company to repurchase any specific amount of stock, and may be modified, suspended, or terminated at any time by the Board.

Chief Executive Officer Gary C. Evans stated that, after a review of US Antimony’s projects in the U.S., Canada, and Mexico and discussion of recent share price performance, the Board unanimously determined the company’s common stock to be undervalued and decided to implement the repurchase program.

United States Antimony Corporation reported second quarter 2026 revenue of $7.9 million, down from $10.5 million in 2025, a roughly 25% decline driven mainly by much lower realized antimony prices. Year-to-date revenue was $14.7 million versus $17.5 million a year earlier. Despite higher antimony volumes, gross profit fell to $0.6 million with a 7% margin, compared with $2.8 million and 27% margin, as pricing pressure outweighed cost reductions.

Operating expenses rose to $7.6 million from $2.8 million, largely due to $2.9 million of share-based compensation and higher staffing and professional fees, resulting in an operating loss of about $7 million. Net income was roughly $0.1 million, supported by a $6.8 million unrealized gain on the Larvotto Resources investment and $0.4 million of interest and investment income.

Liquidity improved significantly: cash was $41.4 million and U.S. Treasuries $20.7 million, for total liquidity of $62.2 million, with total liabilities of $9.6 million and working capital of $70 million. The company highlighted its $245 million sole-source antimony contract with the Defense Logistics Agency, cumulative orders of about $57.3 million, initial accepted shipments over 80,000 pounds, and strong growth in zeolite revenue, which more than doubled year-over-year. Full-year 2026 revenue guidance was reduced to $60–$75 million, mainly reflecting weaker antimony prices.

United States Antimony Corporation reported second quarter 2026 revenues of $7.9 million, down from $10.5 million a year earlier, as antimony prices fell sharply. Antimony segment revenue declined to $5.9 million despite a 26% increase in pounds sold, with average selling price dropping to $13.70 per pound from $28.32, and gross margin compressing to 7% from 27%. Operating expenses rose to $7.6 million, leading to an operating loss of $7.0 million, but a $6.8 million unrealized gain on the Larvotto Resources investment and higher interest income resulted in net income of $0.1 million.

Liquidity strengthened, with cash and cash equivalents of $41.4 million and total investments in U.S. Treasury securities of $20.7 million as of June 30, 2026, supported by $49.1 million in net equity proceeds and $2.0 million from warrant exercises. Inventory increased to $21.6 million, a 178% rise from year-end, reflecting strategic antimony feedstock buildup for commercial and Defense Logistics Agency deliveries, including DLA antimony ingot orders totaling $57.3 million. Zeolite revenue more than doubled to $1.9 million. The company cut full-year 2026 revenue guidance to $60–$75 million from $125 million due to lower antimony prices and shifted DLA shipment timing, while highlighting government grant funding of $12.8 million and ongoing Thompson Falls and Radersburg capacity expansions.

United States Antimony Corporation scheduled the release of its financial and operating results for the second quarter and six months ended June 30, 2026, after U.S. markets close on Tuesday, August 11, 2026. A conference call and webcast will follow that day at 4:15 p.m. Eastern time.

The company provided webcast and dial-in details, including a toll-free and international number plus an access code, and stated that a replay will be available on its investor website. It also outlined its operations in antimony, zeolite, and precious metals and noted prior acquisitions of mining claims and properties in Alaska, Montana, and Ontario beginning in 2024.

United States Antimony Corporation reported results from its 2026 Annual Shareholders Meeting held on June 12, 2026. The company stated that each proposal received the requisite votes for approval. Director nominees drew strong support, with Lloyd Joseph Bardswich receiving 48,579,499 votes for and minimal abstentions. Other nominees, including Gary C. Evans, John M. Keane, and others, were also elected with large majorities. Two additional proposals each obtained substantial "for" votes, including one with 73,504,344 votes in favor, confirming overall shareholder support for the company’s agenda.

United States Antimony Corporation reported a change in its outside auditor driven by a firm acquisition. On June 3, 2026, Assure CPA, LLC was acquired by Sadler Gibb & Associates, LLC, and Assure effectively resigned as the company’s independent registered public accounting firm.

The Audit Committee and full Board approved engaging Sadler Gibb as the new independent registered public accounting firm for the fiscal year ending December 31, 2026. Assure’s audit reports on the 2025 and 2024 financial statements contained no adverse opinions, disclaimers, or qualifications.

The company states there were no disagreements or reportable events with Assure through June 3, 2026. The lead engagement partner and professional staff who handled prior audits have moved to Sadler Gibb, providing continuity for future audits.

United States Antimony Corporation used its latest update to outline a mixed first quarter of 2026 and an aggressive growth plan. Sales were $6.8 million, roughly in line with last year’s $7 million, but the company reported a net loss of $11.3 million, driven mainly by $4.8 million of non-cash stock compensation, a $4.1 million unrealized loss on Larvotto equity, and higher costs tied to ramping operations.

Management emphasized a strong balance sheet, with $60.2 million in cash, U.S. Treasuries, and equity securities at quarter-end, plus $12.8 million received afterward from a $27 million U.S. government expansion grant and $48.6 million of equity proceeds. Inventory rose to $22 million as the company builds feedstock for higher antimony production.

The call focused heavily on growth initiatives: expanding the Thompson Falls smelter toward roughly 230 tons per month of new capacity, ramping Mexican and Bolivian antimony supply, and preparing a hydrometallurgical plant in Idaho targeting 1,000 tons per month of 99.9% pure antimony by 2028. The company is also advancing tungsten at the Fostung deposit in Canada, where an inferred resource of 14.62 million tonnes grading 0.17% WO3 was cited, and a Nolan Creek antimony-gold project in Alaska with previously reported high-grade resources.

In zeolites, the BRZ division launched a cattle nutrition segment and reported record shipment tonnage in March and April, with March about 60% higher than the prior year and both months exceeding internal targets by over 40% and 60%, respectively. Management reiterated 2026 revenue guidance of $125 million, expecting $75 million to $95 million of that from antimony ingot deliveries under U.S. government contracts, supported by existing inventory, new mine plans, and expanding processing capacity.

United States Antimony Corporation reported first quarter 2026 revenue of $6.8 million and a net loss of $11.3 million, reversing a small profit a year earlier. Gross margin fell to about 16% from 34% as higher-cost antimony flowed through cost of sales and volumes dropped.

Operating expenses rose to $8.6 million from $2.0 million, driven largely by $4.8 million of non-cash share-based compensation tied to leadership hiring and share price appreciation. The company recorded a $4.1 million unrealized loss on its Larvotto Resources equity investment.

US Antimony invested heavily, with $12.6 million in capital expenditures for the Radersburg flotation mill, Thompson Falls smelter expansion, and new mineral rights. It recognized $12.8 million of Department of War grant milestones as a reduction of construction-in-progress and ended the quarter with liquid resources of $23.7 million. Post-quarter, it raised roughly $48.6 million by selling about 4.2 million shares and reiterated full-year 2026 gross revenue guidance of approximately $125 million, weighted to the second half of the year.

United States Antimony Corporation announced that Chief Financial Officer Richard Isaak has begun a temporary personal leave of absence effective May 4, 2026. The company states the leave is strictly personal and unrelated to financial performance, accounting, internal controls, or financial reporting.

The Board appointed former financial consultant Shawn Winkler, age 50, as Interim Chief Financial Officer and principal financial officer, effective May 4, 2026. Winkler will receive a monthly cash stipend of $20,000 and a one-time grant of 100,000 stock purchase warrants with a strike price set at the April 27, 2026 closing share price.

Mr. Isaak is expected to return after the leave, currently anticipated to last at least two months. The company also reaffirmed plans to release financial results for the quarter ended March 31, 2026 on May 14, 2026, with Winkler leading the financial reporting process and upcoming earnings call.

United States Antimony Corporation plans to release its first quarter 2026 financial and operating results after U.S. markets close on Thursday, May 14, 2026. Senior management will host a conference call and webcast that day at 4:15 p.m. Eastern time.

The company describes itself as a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia. It mines and processes antimony products and zeolite across facilities in the U.S., Mexico, Canada, and Idaho.

United States Antimony Corporation provided an operational update on its Fostung Project, an intermediate-stage tungsten exploration asset in Ontario, Canada. The company made available a Technical Report Summary (TRS) on the Fostung Tungsten Property, effective January 31, 2026, prepared in accordance with subpart 1300 of Regulation S‑K.

The TRS was completed by SRK Consulting (Canada), Inc., which is identified as a Qualified Person under the regulation. The Fostung Project consists of 50 contiguous single-cell mining claims covering 1,109 hectares and hosts a skarn-type tungsten (scheelite) deposit with associated molybdenum, copper, and silver mineralization. The project is directly owned by UAMY Cobalt Corporation, a wholly owned subsidiary of the company.

The company includes a standard cautionary note that the operational update and related TRS contain forward-looking statements subject to various risks and uncertainties, and it incorporates the TRS as Exhibit 99 to this report.

United States Antimony Corporation reported a breakout 2025 with sharp growth but still a net loss. Sales reached $39.3 million, up 163% year over year, while gross profit rose $6.4 million and gross margin improved from 23% to 25%.

The company recorded a net loss of $4.3 million versus $1.7 million in 2024, largely driven by $6.7 million of non-cash expenses, mainly stock-based compensation. Liquidity strengthened significantly, with cash, U.S. Treasuries and equity securities totaling $91.3 million at 2025 year-end, up from $18.2 million, and working capital of $44.6 million. Debt remained very low at $195,000.

Management highlighted two 5‑year sales contracts totaling about $354 million, including a sole‑source U.S. government antimony ingot contract now sized at $248 million and an industrial antimony contract of $106.7 million. They expect roughly $75 million of antimony ingot deliveries in fiscal 2026 and guided to $125 million of 2026 revenue.

The company became fully vertically integrated in its Antimony Division, expanded ore sources, and is tripling capacity at the Thompson Falls smelter. It is also developing a new hydrometallurgical facility in Idaho with Americas Gold and Silver and received a $27 million USDOW award to help fund expansion.

On the resource side, US Antimony advanced multiple critical mineral projects. At the Fostung tungsten project in Ontario, an independent S‑K 1300 technical report estimated an inferred mineral resource of 14.77 million metric tons grading 0.17% WO₃, containing 54.17 million pounds of tungsten, with a stated future value of about $4.6 billion based on recent pricing. In Alaska, the company acquired the Nolan Creek property with a prior reserve estimate of 42,400 tons grading 28% antimony and 0.408 ounces of gold per ton, with an in‑situ metal value described as close to $7,000 per ton, implying roughly $297 million of metal value at stated prices.

Management emphasized rapid development at Stibnite Hill in Montana, where about 800 tons of 10% antimony ore were mined and trucked in 2025, and indicated plans to restart mining after winter. They also noted elevated antimony inventory of 465 tons at year-end, up from 78 tons, to support government contract deliveries.

Bear River Zeolite, the company’s zeolite division, is being repositioned under new leadership to focus on water treatment and agriculture. Water treatment currently represents about 75% of its revenue, and the operation benefits from a previously filed reserve report indicating an estimated 400‑year reserve life of high-quality zeolite. Management is pursuing more bulk business, infrastructure upgrades, and long-term supply contracts to improve margins and scale.

Investor relations reported a major shift in the shareholder base. The share price increased from $1.78 to $5.02 during 2025, with market capitalization rising from $201 million to $703 million. Institutional holders grew from 48 to 222, with approximately 40% institutional ownership and average daily trading volume near 15 million shares. The company also uplisted to the NYSE main board and highlighted its positioning as a domestic critical minerals supplier aligned with U.S. national security priorities.

United States Antimony Corporation reported very strong 2025 growth but remained unprofitable. Revenue jumped 163% to $39.26 million, driving gross profit up 185% to $9.87 million and improving gross margin to 25% from 23%.

Higher operating expenses of $18.33 million, including $7.08 million of non‑cash share‑based compensation, led to a net loss of $4.34 million versus a $1.73 million loss in 2024. The company raised over $110 million from equity offerings and warrant exercises, ending 2025 with $91.3 million in cash and investments and funding $27.8 million of capital spending.

USAC highlighted $354 million of new antimony contracts, a roughly 10% equity stake in Larvotto Resources for $37.2 million, antimony inventories rising to 465 tons, and reiterated 2026 gross revenue guidance of $125 million, citing tight global antimony and tungsten markets as key tailwinds.

United States Antimony Corporation is notifying investors that it will release its fiscal year 2025 financial and operating results after U.S. markets close on Thursday, March 19, 2026. Management will host a conference call and webcast that afternoon at 4:15 p.m. Eastern time, with access details provided in the accompanying press release.

The company describes itself as a leading producer and processor of antimony, zeolite, and other critical minerals, with integrated mining and processing operations in the U.S., Mexico, and Canada. It highlights recent acquisitions of mining claims and properties in Alaska, Montana, Alabama, and Ontario during 2024 and 2025 to reduce reliance on third-party antimony ore and broaden its product offerings.

United States Antimony Corporation announced that the New York Stock Exchange has approved the uplisting of its common stock from NYSE American to the NYSE. The company expects its shares to begin trading on the NYSE on March 11, 2026 under the symbol “UAMY.”

Until the transfer is complete, the stock will continue to trade on NYSE American, also under “UAMY.” The company will remain listed on the NYSE Texas Exchange with the same ticker. Current shareholders are not required to take any action in connection with this uplisting.

United States Antimony Corporation is furnishing an investor presentation that outlines major growth, contracts, and expansion plans. The Company reports 2025 revenue of $26.2 million, up from $9.3 million in 2024, and 2025 gross profit of $7.2 million versus $2.3 million in 2024, reflecting increases of 182% and 219%, respectively. As of December 31, 2025, cash, federal funds, and marketable securities totaled approximately $90–92 million, while market capitalization reached about $1,205.7 million as of February 6, 2026. The presentation highlights a sole-source $245 million contract with the U.S. Defense Logistics Agency and a $106.7 million agreement with a large U.S. industrial fabric manufacturer, along with new international ore supply agreements, smelter expansions, a hydrometallurgical joint venture in Idaho, and growing mining claims for antimony, tungsten, cobalt, and other minerals across the U.S., Canada, and Mexico.

United States Antimony Corporation (US Antimony) has entered a new joint venture with Americas Gold and Silver Corporation to build and operate a state-of-the-art hydromet processing facility in Idaho.

The joint venture will be owned 51% by Americas and 49% by US Antimony, with US Antimony serving as the managing member and major decisions handled by a committee with equal representation from both partners. The plant will process copper, silver, and antimony from Americas’ adjacent mines, aiming for higher recoveries at significantly lower cost, which is expected to improve JV profitability.

The facility is described as the first commercial-scale hydromet processing center of its kind in North America, using technology for which UAMY holds an exclusive license. The Idaho site has already secured all key permits other than construction permits, allowing construction planning to begin. The partners also state they have prepared paperwork to seek potential U.S. government funding aligned with national critical mineral objectives.

United States Antimony Corporation furnished an update on a strategic project in Bolivia. Since mid-2025, the company has been funding and helping develop a new hydrometallurgical processing facility designed to refine antimony and other critical minerals on a commercial scale. The facility is associated with a project located in Bolivia, which could expand the company’s role in the antimony supply chain if successfully advanced. Details are provided in a press release attached as an exhibit, and the company emphasizes that related statements are forward-looking and subject to significant risks and uncertainties.

United States Antimony Corporation reported that it has closed on the acquisition of a critical minerals flotation facility located in Radersburg, Montana. The facility, which is fully operational and situated between Helena and Bozeman, was acquired on January 16, 2026 for $4.75 million in cash, representing an immediate investment outflow.

The company has also budgeted approximately $2 million in future capital expenditures to make specific improvements to the newly acquired property and equipment. Details of the transaction and planned upgrades are described further in a related press release furnished as an exhibit.

United States Antimony Corporation filed a current report to let investors know it has issued a new shareholder letter. The company states that the letter, dated January 5, 2026, has been provided as Exhibit 99.1 to this report and is incorporated by reference. The information is furnished under Regulation FD, which means it is intended to share the same information with all investors at the same time rather than being treated as formally filed financial statements.

United States Antimony Corporation (UAMY) reported that its Board of Directors has appointed Jon R. Marinelli as a new director, effective November 24, 2025. With his addition, the Board increases to seven members, of which five are independent, and he will also serve as Chairman of a newly formed Finance Committee.

Marinelli brings more than 25 years of experience in capital markets, M&A, and strategic advisory work, including leadership roles at BMO Capital Markets and Deutsche Bank’s natural resources group, and has advised on over $285 billion in transactions. He will serve until the next annual shareholder meeting under the company’s standard non-employee director compensation program, and there are no related-party transactions requiring disclosure.

United States Antimony Corporation furnished an 8-K under Item 2.02 to provide the transcript of its conference call discussing financial and operational results for the third quarter and nine months ended September 30, 2025. A replay is available on the company’s website until November 26, 2025.

The transcript is attached as Exhibit 99.1 and is being furnished, not filed, which limits potential liability under the Exchange Act. The filing also includes customary forward‑looking statements cautions.

United States Antimony Corporation furnished a press release reporting its financial and operational results for the third quarter and nine months ended September 30, 2025.

The press release was provided as Exhibit 99.1 to this Form 8-K under Item 2.02 and is incorporated by reference. The information in Item 2.02, including Exhibit 99.1, is being furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The company also included customary forward‑looking statements language.

United States Antimony Corporation entered into a five-year supply agreement with a large U.S. industrial fabric manufacturer for antimony trioxide, a key ingredient in flame‑retardant materials. The agreement was executed on November 7, 2025 and reflects a multi‑year commercial commitment for product sales.

The company announced the deal via press release on November 11, 2025. The purchasing and supply agreement is filed as Exhibit 10.1, with a press release attached as Exhibit 99.1.

United States Antimony Corporation announced the schedule for releasing its Third Quarter and Nine Months Ended September 30, 2025 financial and operating results. The company will host a conference call and webcast on November 12, 2025 at 4:15 p.m. Eastern time.

Access details are provided in a press release attached as Exhibit 99.1. The information was furnished under Item 8.01 and is not deemed filed under Section 18 of the Exchange Act.

United States Antimony Corporation filed a Form 8-K stating it issued a press release on October 30, 2025 with an operational update and a preliminary update to Fiscal 2026 revenue guidance. The press release is included as Exhibit 99.1.

The company furnished this information under Item 7.01 (Regulation FD Disclosure), which means it is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically noted.

United States Antimony Corporation (UAMY) filed an 8‑K announcing a non‑binding, indicative proposal to acquire Larvotto Resources Limited. On October 17, 2025, USAC submitted terms offering six (6) USAC shares for every one hundred (100) Larvotto shares. The company also disclosed it has recently acquired approximately 10% of Larvotto’s ordinary shares.

The proposal is subject to negotiation and execution of a binding scheme implementation deed, Larvotto shareholder approval, regulatory approvals, and customary closing conditions. USAC furnished a related press release under Regulation FD. The disclosure outlines the proposed share‑for‑share ratio and approvals required, indicating an early, non‑binding stage in a potential combination.

United States Antimony Corporation filed a prospectus supplement for an at‑the‑market program to offer and sell up to $400,000,000 of common stock under its automatic shelf registration on Form S‑3. Sales may be made through A.G.P./Alliance Global Partners and B. Riley Securities pursuant to an amended and restated sales agreement.

Offerings will be made only by means of the prospectus supplement and the base prospectus. A legal opinion from Duane Morris LLP regarding the validity of the shares was filed as Exhibit 5.1.

United States Antimony Corporation entered a Securities Purchase Agreement for a registered direct offering of 2,377,657 shares of common stock at $10.50 per share, for approximately $25 million in gross proceeds. The company expects net proceeds of $24,431,090.53 after the placement commission and a credit, with closing expected on or about October 14, 2025, subject to customary conditions.

The deal is being made off the company’s effective Form S-3 shelf and a Rule 462(b) S-3MEF. Titan Partners Group acted as exclusive placement agent with a 7% commission, subject to a credit. Separately, the company reduced its ATM capacity from $65,000,000 to $39,885,000 effective October 6, 2025, and as of October 10, 2025, cannot sell under the existing ATM prospectus supplement unless and until new offering documents are filed; the sales agreement remains in force.

United States Antimony Corporation entered into a Securities Purchase Agreement on October 6, 2025 for a registered direct offering of 3,500,000 shares of common stock at $7.50 per share. This will provide aggregate gross proceeds of approximately $26,250,000, with expected net proceeds of $25,558,750 after placement agent fees, a credit, and other expenses.

A.G.P./Alliance Global Partners acted as exclusive placement agent and will receive a 7% commission on the Offering’s gross proceeds, subject to a credit on the closing date. The Offering is being made under the company’s effective Form S-3 shelf registration statement and is expected to close on or about October 7, 2025, subject to customary conditions.

The company also adjusted its at-the-market (“ATM”) offering program. It reduced the ATM prospectus supplement’s aggregate offering price from $65,000,000 to $39,885,000. After accounting for $9,775,549 of prior ATM sales, the company may offer up to an additional $30,109,451 of common stock under the current ATM limit, while the underlying sales agreement with the agents remains in effect.

United States Antimony Corporation filed a Form 8-K to share that, on October 6, 2025, it issued a press release announcing the pricing of a registered direct offering. The company is using this current report to make the information broadly available under Regulation FD, which is designed to ensure that all investors receive important company information at the same time.

The press release, dated October 6, 2025, is included as an exhibit to the report and is incorporated by reference. The company also clarifies that this disclosure is being treated as “furnished” rather than “filed,” which limits how it is used for certain legal liability purposes under the securities laws.

United States Antimony Corporation disclosed that it has been awarded a $245 million sole-source, five-year contract from the U.S. Defense Logistics Agency to supply antimony ingots. This long-term government contract provides a defined revenue stream tied to antimony deliveries over the contract term. The company announced the award in a press release dated September 23, 2025, which is furnished as an exhibit and not treated as filed for liability purposes.

United States Antimony Corporation entered into an Amended and Restated Sales Agreement with A.G.P./Alliance Global Partners and B. Riley Securities to sell common stock through an at-the-market offering program. The agreement adds B. Riley as a sales agent and updates related terms.

The company filed a prospectus supplement to allow issuance of up to $65,000,000 of common shares under this program using its existing shelf registration. The company will set limits on timing, size, and minimum prices for sales, may suspend sales at its discretion, and will pay the sales agents up to 3.0% of gross proceeds as commission.

United States Antimony Corporation appointed General (Ret.) John M. “Jack” Keane to its Board of Directors, effective August 13, 2025. He is a prominent foreign policy and national security authority who advises presidents, cabinet officials, members of congress, international leaders, and business leaders, and serves as Chairman of the Institute for the Study of War and as a member of the Secretary of Defense Policy Board.

General Keane will serve as a director until the next annual meeting of shareholders and until a successor is elected and qualified, or until an earlier death, resignation, or removal. The company states there are no special arrangements or related-party transactions associated with his selection, and his compensation will follow the standard program for non-employee directors. United States Antimony later issued a press release on August 19, 2025 announcing his appointment.

United States Antimony Corporation furnished an update on its recent performance by providing access to a conference call discussing financial and operational results for the second quarter and six months ended June 30, 2025. The call was held on August 12, 2025, and a recorded replay is available on the company’s investor website until August 26, 2025.

The company is also making a written transcript of this conference call available as Exhibit 99.1, which is furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws and is not automatically incorporated into other SEC filings.

United States Antimony Corporation filed a current report stating that on August 12, 2025 it issued a press release with its financial and operational results. The press release covers the second quarter and six months ended June 30, 2025 and is furnished as Exhibit 99.1 and incorporated by reference.

The company notes that this information is being furnished, not filed under the Exchange Act, which affects how it is treated for certain legal liability purposes. The report is signed on behalf of the company by Richard R. Isaak, Senior Vice President and Chief Financial Officer.

On 31 July 2025 United States Antimony Corporation (NYSE American: UAMY) held its annual shareholders’ meeting and disclosed the final voting results in this Form 8-K (Item 5.07). All five director nominees—Gary C. Evans, Dr. Blaise Aguirre, Lloyd J. Bardswich, Joseph A. Carrabba and Michael A. McManus—were elected for one-year terms ending in 2026.

Shareholders also approved: (1) reincorporation from Montana to Texas (20.6 m for / 11.8 m against / 59 k abstain); (2) the Amended & Restated 2023 Equity Incentive Plan (25.7 m for); (3) an advisory “say-on-pay” resolution (30.5 m for, 1.7 m against); and (4) ratification of Assure CPA, LLC as independent auditor for FY 2025 with 67.1 m for versus 1.1 m against.

While every proposal obtained the required majority, the reincorporation vote shows notable dissent (≈36 % of votes cast). No financial guidance or operating results were provided.

United States Antimony Corp. (NYSE: UAMY) filed an 8-K dated 24 Jul 2025 to disclose completion of its first Technical Report Summary (TRS) for the Bear River Zeolite Project in Preston, Idaho. The TRS, prepared under SEC Regulation S-K sub-part 1300, is provided as Exhibit 96.1; a related press release is Exhibit 99.1. The filing places the disclosure under Item 7.01 (Reg FD) and Item 8.01 (Other Events), meaning the information is furnished—not filed—and therefore carries reduced Exchange Act liability.

The company highlights that the TRS “summarizes the Project’s economic viability under current operating and market conditions,” but the 8-K does not include specific production, reserve, cost, or cash-flow figures. By publishing a compliant TRS, UAMY increases transparency of its zeolite subsidiary, Bear River Zeolite Co., and signals intent to develop or expand the operation. Forward-looking-statement language warns that actual outcomes may differ from current expectations.

No changes to guidance, financial results, or major transactions are reported.

On June 27, 2025, United States Antimony Corporation (NYSE American: UAMY) received authorization from NYSE Texas, Inc. to list its common stock on that exchange. Trading on NYSE Texas is expected to begin on Tuesday, July 1, 2025, under the existing “UAMY” ticker symbol. The company will retain its primary listing on the NYSE American, thereby becoming dual-listed.

The information is furnished under Item 8.01 of this Form 8-K and is accompanied by a press release (Exhibit 99.1) announcing the listing. No changes to capital structure, operations, or guidance were disclosed, and no other material transactions were reported.

• Liquidity & Visibility: A second U.S. trading venue may broaden the shareholder base and improve daily trading volumes.
• No operational disruption: Ticker symbol, par value, and existing exchange relationship remain unchanged.
• Non-financial filing: The report is informational only; it does not include earnings, forecasts, or financing details.

While the filing does not alter fundamentals, the added exchange presence could incrementally enhance market access and price discovery over time.